Systemic immunization with streptococcal immunoglobulin-binding protein Sib35 induces protective immunity against group a Streptococcus challenge in mice

Vaccine

Volumn 23, Issue 40, 2005, Pages 4852-4859

  Okamoto, Shigefumi ^a,b   Tamura, Yasuharu ^a   Terao, Yutaka ^a   Hamada, Shigeyuki ^a   Kawabata, Shigetada ^a,c  

^a OSAKA UNIVERSITY   (Japan)

^b FUKUOKA DENTAL COLLEGE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Group A Streptococcus pyogenes (GAS); Immunization; Protection; Sib35

Indexed keywords

FREUND ADJUVANT; IMMUNOGLOBULIN G ANTIBODY; OPSONIN; RECOMBINANT STREPTOCOCCAL IMMUNOGLOBULIN BINDING PROTEIN 35; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNITY; IMMUNIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SERUM; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; SURVIVAL RATE;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; OPSONIN PROTEINS; PHAGOCYTOSIS; RABBITS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES;

EID: 24144501079     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.02.035     Document Type: Article

References (33)

1. F. Baxter Severe group A streptococcal infection and streptococcal toxic shock syndrome Can J Anesth 47 2000 1129 1140
2. N.C. Engleberg, A. Heath, K. Vardaman, and V.J. DiRita Contribution of CsrR-regulated virulence factors to the progress and outcome of murine skin infections by Streptococcus pyogenes Infect Immun 72 2004 623 628
3. R. Kaul, A. McGeer, D.E. Low, K. Green, B. Schwartz Ontario Group A Streptococcal Study, et al. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indications, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study Am J Med 103 1997 18 24
4. K. Nakashima, S. Ichiyama, Y. Iimura, Y. Hamsegawa, M. Ohta, and K. Ooe A clinical and bacteriologic investigation of invasive streptococcal infections in Japan on the basis of serotypes, toxin production and genomic DNA fingerprints Clin Infect Dis 25 1997 260 266
5. S. Okamoto, S. Kawabata, I. Nakagawa, Y. Okuno, T. Goto, and K. Sano Influenza A virus-infected hosts boost invasive type of Streptococcus pyogenes infection in mice J Virol 77 2003 4104 4112
6. W.W. Navarre, and O. Schneewind Surface proteins of Gram-positive bacteria and mechanisms of their targeting to the cell wall envelop Microbiol Mol Biol Rev 63 1999 174 229
7. M.W. Cunningham Pathogenesis of group A streptococcal infections Clin Microbiol Rev 13 2000 470 511
8. P. Åkesson, J. Cooney, F. Kishimoto, and L. Björck Protein H: a novel IgG binding bacterial protein Mol Immunol 27 1990 523 531
9. G. Lindahl, and B. Åkerstrom Receptor for IgA in group A streptococci: cloning of the gene and characterization of the protein expressed in Escherichia coli Mol Microbiol 3 1989 239 247
10. L. Stenberg, P.W. O'Toole, J. Mestecky, and G. Lindahl Molecular characterization of protein Sir, a streptococcal cell surface protein that binds both immunoglobulin A and immunoglobulin G J Biol Chem 269 1994 13458 13464
11. S. Kawabata, Y. Tamura, J. Murakami, Y. Terao, I. Nakagawa, and S. Hamada A novel, anchorless streptococcal surface protein that binds to human immunoglobulins Biochem Biophys Res Commun 296 2002 1329 1333
12. B. Lei, F.R. DeLeo, N.P. Hoe, M.R. Graham, S.M. Mackie, and R.L. Cole Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis Nat Med 7 2001 1298 1305
13. U. von Pawel-Rammingen, B.P. Johansson, and L. Björck IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G EMBO J 21 2002 1607 1615
14. H.S. Courtney, J.B. Dale, and D.L. Hasty Differential effects of the streptococcal fibronectin-binding protein, FBP54, on adhesion of group A streptococci to human buccal cells and Hep-2 tissue culture cells Infect Immun 64 1996 2415 2419
15. S. Kawabata, E. Kunitomo, Y. Terao, I. Nakagawa, K. Kikuchi, and K. Totsuka Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice Infect Immun 69 2001 924 930
16. K. Schulze, E. Medina, G.S. Chhatwal, and C.A. Guzmán Stimulation of long-lasting protection against Streptococcus pyogenes after intranasal vaccination with non adjuvanted fibronectin-binding domain of the SfbI protein Vaccine 21 2003 1958 1964
17. K. Schulze, E. Medina, S.R. Talay, R.J. Towers, G.S. Chhatwal, and C.A. Guzmán Characterization of the domain of fibronectin-binding protein I of Streptococcus pyogenes responsible for elicitation of a protective immune response Infect Immun 69 2001 622 625
18. S. Okamoto, S. Kawabata, I. Nakagawa, and S. Hamada Administration of superantigens protects mice from lethal Listeria monocytogenes infection by enhancing cytotoxic T cells Infect Immun 69 2001 6633 6642
19. S. Okamoto, S. Kawabata, H. Fujitaka, T. Uehira, Y. Okuno, and S. Hamada Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza-Streptococcus pyogenes superinfection Vaccine 22 2004 2887 2893
20. J.B. Dale, E.Y. Chiang, S. Liu, H.S. Courtney, and D.L. Hasty New protective antigen of group A streptococci J Clin Invest 103 1999 1261 1268
21. T. Miethke, C. Wahl, K. Heeg, B. Echtenacher, B.P. Krammer, and H. Wagner T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor J Exp Med 175 1992 91 98
22. J.B. Dale, and E.H. Beachey Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein J Exp Med 163 1986 1191 1202
23. D.L. Hasty, I. Ofek, H.S. Courtney, and R.J. Doyle Multiple adhesins of streptococci Infect Immun 60 1992 2147 2152
24. P.G. Fenderson, V.A. Fischetti, and M.W. Cunningham Tropomyosin shares immunologic epitopes with group A streptococcal M proteins J Immunol 142 1989 2475 2481
25. B. Hosein, M. McCarty, and V.A. Fischetti Amino acid sequence and physicochemical similarities between streptococcal M protein and mammalian tropomyosin Proc Natl Acad Sci USA 76 1979 3765 3768
26. B. Eriksson, K.J. Andersson, S.E. Holm, and M. Norgren Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome Clin Infect Dis 27 1998 1428 1436
27. D.R. Johnson, D.L. Stevens, and E.L. Kaplan Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis J Infect Dis 166 1992 374 382
28. P.L. Ho, D.R. Johnson, A.W.Y. Yue, D.N.C. Tsang, T.L. Que, and B. Beall Epidemiologic analysis of invasive and noninvasive group A streptococcal isolates in Hong Kong J Clin Microbiol 41 2003 937 942
29. B.J.M. Vlaminckx, E.M. Mascini, J. Schellekens, L.M. Schouls, A. Paauw, and A.C. Fluit Site-specific manifestations of invasive group A streptococcal diseases: type distribution and corresponding patterns of virulence determinants J Clin Microbiol 41 2003 4941 4949
30. C.-S. Hsieh, S.E. Macatonia, A. O'Garra, and K.M. Murphy T cell genetic background determines default T helperphenotype development in vitro J Exp Med 181 1995 713 721
31. E. Kuroda, T. Kito, and U. Yamashita Reduced expression of STAT4 and IFN-γ in macrophages from BALB/c mice J Immunol 168 2002 5477 5482
32. C.A. Guzmán, S.R. Talay, G. Molinari, E. Medina, and G.S. Chhatwal Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin-binding protein SfbI J Infect Dis 179 1998 901 906
33. J.C. Eisenberg, S.J. Czinn, C.A. Garhart, R.W. Redline, W.C. Bartholomae, and J.M. Gottwein Protective efficacy of anti-Helicobacter pylori immunity following systemic immunization of neonatal mice Infect Immun 71 2003 1820 1827